Literature DB >> 6130829

Chronic infusion of endogenous excitatory amino acids into rat striatum and hippocampus.

R M Mangano, R Schwarcz.   

Abstract

The effects of chronic intrastriatal and intrahippocampal infusions of endogenous excitatory amino acids were examined on the light microscopic level. Repeated manual injections of either glutamate or aspartate (1.8 mumoles/0.5 mu 1 every 12 hours for 14 days), but not of equimolar GABA, caused neuronal degeneration proximal to the tip of the injection cannula. Nerve cell death was limited to a spherical area with a radius of approximately 0.5 mm. Continuous infusion of these amino acids via osmotic minipumps, at total daily doses identical to those used in the experiments employing manual injections, did not result in lesions in striatum or hippocampus. Attempts using minipump administration of cysteine sulfinate or combinations of glutamate with aspartate, cysteine sulfinate or DL-threo-beta-hydroxyaspartate were equally unsuccessful in producing neuronal cell loss. The efficient re-uptake systems for the endogenous amino acids may suffice to continuously remove large quantities of the infused compounds from vulnerable neuronal sites. It appears, however, that these protective mechanisms can be overcome by extremely high local concentrations of glutamate or aspartate. Possible implications for the pathogenesis of human neurodegenerative disorders are discussed.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6130829     DOI: 10.1016/0361-9230(83)90073-4

Source DB:  PubMed          Journal:  Brain Res Bull        ISSN: 0361-9230            Impact factor:   4.077


  13 in total

1.  Neuroprotective effects of N-methyl-D-aspartate receptor antagonist on aspartate induced neurotoxicity in the spinal cord in vivo.

Authors:  Yasunori Cho; Toshihiko Ueda; Atsuo Mori; Hideyuki Shimizu; Ryohei Yozu
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2003-10

2.  The glutamate transporter GLT1a is expressed in excitatory axon terminals of mature hippocampal neurons.

Authors:  Weizhi Chen; Veeravan Mahadomrongkul; Urs V Berger; Merav Bassan; Tara DeSilva; Kohichi Tanaka; Nina Irwin; Chiye Aoki; Paul A Rosenberg
Journal:  J Neurosci       Date:  2004-02-04       Impact factor: 6.167

3.  Cellular and subcellular mRNA localization of glutamate transporter isoforms GLT1a and GLT1b in rat brain by in situ hybridization.

Authors:  Urs V Berger; Tara M DeSilva; Weizhi Chen; Paul A Rosenberg
Journal:  J Comp Neurol       Date:  2005-11-07       Impact factor: 3.215

4.  Diffuse brain injury elevates tonic glutamate levels and potassium-evoked glutamate release in discrete brain regions at two days post-injury: an enzyme-based microelectrode array study.

Authors:  Jason M Hinzman; Theresa Currier Thomas; Jason J Burmeister; Jorge E Quintero; Peter Huettl; Francois Pomerleau; Greg A Gerhardt; Jonathan Lifshitz
Journal:  J Neurotrauma       Date:  2010-05       Impact factor: 5.269

5.  Glutamate enhances brain damage and albumin content in cerebrospinal fluid after intracarotid protamine infusion.

Authors:  I Westergren; C Nordborg; B B Johansson
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

6.  Neurochemical effects of L-pyroglutamic acid.

Authors:  C F de Mello; D D De La Vega; L T Pizutti; F P Lopes; M A Rubin; J G Homerich; C R Melo; J E Somer; D O Souza; M Wajner
Journal:  Neurochem Res       Date:  1995-12       Impact factor: 3.996

Review 7.  The role of glutamate transporters in neurodegenerative diseases and potential opportunities for intervention.

Authors:  Amanda L Sheldon; Michael B Robinson
Journal:  Neurochem Int       Date:  2007-04-19       Impact factor: 3.921

Review 8.  Kynurenines and Glutamate: Multiple Links and Therapeutic Implications.

Authors:  R Schwarcz
Journal:  Adv Pharmacol       Date:  2016-03-11

9.  Long-term homeostasis of extracellular glutamate in the rat cerebral cortex across sleep and waking states.

Authors:  Michael B Dash; Christopher L Douglas; Vladyslav V Vyazovskiy; Chiara Cirelli; Giulio Tononi
Journal:  J Neurosci       Date:  2009-01-21       Impact factor: 6.167

10.  Interaction between the glutamate transporter GLT1b and the synaptic PDZ domain protein PICK1.

Authors:  Merav Bassan; Hongguang Liu; Kenneth L Madsen; Wencke Armsen; Jiayi Zhou; Tara Desilva; Weizhi Chen; Allison Paradise; Michael A Brasch; Jeff Staudinger; Ulrik Gether; Nina Irwin; Paul A Rosenberg
Journal:  Eur J Neurosci       Date:  2008-01       Impact factor: 3.386

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.